Recent data have suggested that the longer-term use of bisphosphonate treatment (particularly > five years) may be associated with increased risk of drug-related side effects, particularly atypical femur fracture. This document outlines an All Wales strategy to modify this risk via reassessment of patients and consideration of ‘drug holidays’. Information provided for prescribers includes a review process for patients prescribed bisphosphonate therapy for five or more years.
|
This resource has been retired and is no longer considered an AWMSG-endorsed resource. The resource underwent an assessment for review in June 2024. At that time members of the All Wales Prescribing Advisory Group (AWPAG) considered it appropriate to retire the resource. The content contained within the resource was considered to be out of date and, without an indication that an updated version of the resource would be of significant benefit to NHS Wales, AWPAG members considered it most appropriate for the resource to be retired at this time. If you think this resource should be reconsidered for review, please get in touch with AWTTC by emailing awttc@nhs.wales.uk. |
⇩ Guidance to Support the Safe Use of Long-term Oral Bisphosphonate Therapy 234KB (PDF) |
(September 2015)
(December 2024 - Retired)